Napirimus

This classification denotes an immunosuppressant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 45081SG6XT. European Medicines Agency schedules Napirimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09156MIG. Napirimus generally arises in the molecular formula C17H13NO3. The term NAPIRIMUS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, list 29.) NAPIRIMUS is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule napirimus under HS 29339990 and SITC 51577. As of Q4 2014, NAPIRIMUS remains US FDA's Preferred Term for this commodity. Napirimus bears US NLM identifiers UMLS ID C2698429 and NCI Concept Code C76694. SMILES: O=C(C1C2C(CCC1)CCCC2)C1CN(C(C1)C(=O)O)C.